Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 1, 1990
24- and 26-homo-1,25-dihydroxyvitamin D3 analogs: potencies on in vitro bone resorption differ from those reported for cell differentiationS K Paulson, K Perlman, H F DeLuca, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|November 1, 1990
Pharmacologic characterization of the rabbit neutrophil receptor for platelet-activating factorS K Paulson, J L Wolf, A Novotney-Barry, et al.
Inflammation|June 1, 1995
Dermal inflammation in primates, mice, and guinea pigs: attenuation by second-generation leukotriene B4 receptor antagonist, SC-53228D J Fretland, R Gokhale, L Mathur, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 19, 2000
Metabolism and excretion of [(14)C]celecoxib in healthy male volunteersS K Paulson, J D Hribar, N W Liu, et al.
Journal of Mass Spectrometry : JMS|December 13, 2000
Characterization of metabolites of Celecoxib in rabbits by liquid chromatography/tandem mass spectrometryJ Y Zhang, Y Wang, C Dudkowski, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 25, 1999
Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxibS K Paulson, L Engel, B Reitz, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 9, 2003
Pharmacokinetics, metabolism and excretion of an inhibitor of inducible nitric oxide synthase, L-NIL-TA, in dogJ Y Zhang, Y F Wang, M N Milton, et al.
Biopharmaceutics & Drug Disposition|March 4, 2000
Plasma protein binding of celecoxib in mice, rat, rabbit, dog and humanS K Paulson, T A Kaprak, C J Gresk, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 17, 2001
Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorptionS K Paulson, M B Vaughn, S M Jessen, et al.
Inflammation|April 1, 1995
Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated eventsD J Fretland, C P Anglin, M Bremer, et al.
Pageof 3